Braun Stacey Associates Inc. Purchases 3,710 Shares of MetLife, Inc. (NYSE:MET)

Braun Stacey Associates Inc. grew its position in shares of MetLife, Inc. (NYSE:METFree Report) by 2.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 165,978 shares of the financial services provider’s stock after buying an additional 3,710 shares during the quarter. Braun Stacey Associates Inc.’s holdings in MetLife were worth $10,976,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. DHJJ Financial Advisors Ltd. bought a new stake in shares of MetLife in the 3rd quarter worth approximately $25,000. FWL Investment Management LLC bought a new stake in shares of MetLife in the 4th quarter worth approximately $26,000. Quintet Private Bank Europe S.A. bought a new stake in shares of MetLife in the 3rd quarter worth approximately $28,000. Planned Solutions Inc. bought a new stake in shares of MetLife in the 4th quarter worth approximately $28,000. Finally, Eagle Bay Advisors LLC bought a new stake in shares of MetLife in the 2nd quarter worth approximately $28,000. Institutional investors own 89.81% of the company’s stock.

MetLife Stock Up 0.5 %

MET opened at $73.57 on Thursday. The company has a fifty day moving average price of $70.35 and a 200-day moving average price of $66.20. The firm has a market capitalization of $53.19 billion, a P/E ratio of 40.20, a price-to-earnings-growth ratio of 0.55 and a beta of 1.04. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a one year low of $48.95 and a one year high of $74.39.

MetLife (NYSE:METGet Free Report) last announced its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a return on equity of 19.48% and a net margin of 2.36%. The company had revenue of $18.72 billion during the quarter, compared to analysts’ expectations of $18.07 billion. Equities research analysts expect that MetLife, Inc. will post 8.81 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, March 14th. Investors of record on Tuesday, February 6th were given a $0.52 dividend. The ex-dividend date was Monday, February 5th. This represents a $2.08 annualized dividend and a yield of 2.83%. MetLife’s dividend payout ratio (DPR) is presently 113.66%.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Wells Fargo & Company lowered their price target on shares of MetLife from $85.00 to $83.00 and set an “overweight” rating on the stock in a report on Tuesday, February 6th. Keefe, Bruyette & Woods lowered their target price on shares of MetLife from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Thursday, December 7th. UBS Group lowered their target price on shares of MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a report on Monday, February 5th. Finally, The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and boosted their target price for the company from $70.00 to $80.00 in a report on Monday, January 8th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $77.23.

Get Our Latest Stock Analysis on MET

Insider Buying and Selling

In related news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares in the company, valued at $10,567,933.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is owned by company insiders.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.